Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tailoring new gene delivery designs for specific targets.

J M Benns1, S W Kim

  • 1Department of Pharmaceutics and Pharmaceutical Chemistry, Center for Controlled Chemical Delivery, University of Utah, Salt Lake City 84112, USA.

Journal of Drug Targeting
|April 13, 2000
PubMed
Summary

New gene delivery vehicles utilize targeting moieties like low-density lipoprotein (LDL) and lactose for enhanced cell specificity and reduced toxicity. These advanced carriers show improved transfection efficacy compared to traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of aeration and agitation on the production of mycelial biomass and exopolysaccharides in an enthomopathogenic fungus Paecilomyces sinclairii.

Letters in applied microbiology·2003
Same author

Numerical and experimental studies of CCl4 destruction in a dump incinerator.

Environmental technology·2003
Same author

Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.

Bone marrow transplantation·2003
Same author

Effects of protein deprivation on subsequent growth performance, gain of body components, and protein requirements in growing pigs.

Journal of animal science·2003
Same author

Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium.

Gene therapy·2003
Same author

Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.

Hepato-gastroenterology·2003

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Advancements in biotechnology are driving the creation of novel gene delivery vehicles.
  • Targeting specific cell types is crucial for effective gene therapy.
  • Existing methods often face challenges with efficiency and toxicity.

Purpose of the Study:

  • To develop and evaluate novel, targeted gene delivery systems.
  • To assess the efficacy and toxicity of engineered gene carriers.
  • To explore the potential of various targeting moieties for improved gene delivery.

Main Methods:

  • Synthesis and characterization of terplex gene carriers utilizing low-density lipoprotein (LDL).
  • Development of lactose-conjugated poly(L-lysine) (PLL) with poly(ethyl glycol) (PEG) spacers for targeted delivery.

Related Experiment Videos

  • Creation of biodegradable nanoparticles from polysaccharide-graft-PLL and poly(D,L-lactic acid).
  • Investigation of JLI mAb and folic acid conjugation to PLL for specific targeting.

    • Main Results:

    • Terplex carriers efficiently delivered genes to smooth muscle cells with low toxicity.
    • Lactose-conjugated PLL demonstrated preferential targeting of Hep G2 cells, outperforming PEG-PLL and Lipofectin.
    • Biodegradable nanoparticles were controllable in size (down to 60 nm) and showed enhanced DNA adsorption with polysaccharide inclusion.
    • PLL backbone of 20,000 mw proved sufficient for DNA compaction.

    Conclusions:

    • Engineered gene carriers with specific targeting moieties offer improved efficacy and reduced toxicity.
    • Novel systems like terplex, lactose-PLL, and targeted nanoparticles show promise for advanced gene therapy applications.
    • Further research into folic acid-conjugated PLL holds potential for cancer therapy targeting.